This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Human medicines European public assessment report (EPAR): MicardisPlus, Date of ...
Human medicines European public assessment report (EPAR): Nplate, romiplostim, D...
And other biotech news updates, brought to you by The Readout.
Want to stay on top of the science and politics driving biotech today? Sign up t...
The ouster of Peter Marks, the FDA official who oversaw vaccines, gene therapies...
Why the ouster of Peter Marks, a senior FDA official, is a huge deal, whether yo...
BiomX’s acquisition of Adaptive Phage Therapeutics is looking like a good bet no...
Human medicines European public assessment report (EPAR): Efmody, hydrocortisone...
Transcend Therapeutics has glided over the bar for success, linking its MDMA ana...
Human medicines European public assessment report (EPAR): Heplisav B, hepatitis ...
Human medicines European public assessment report (EPAR): Rukobia, fostemsavir, ...
Opthea’s eye disease drug has failed its second phase 3 trial in a week, leaving...
EVVet3 EVWeb Production - Release notes
Cologuard is getting an upgrade after 10 years on the market. Exact Sciences sai...
For the first time, all the 27 countries of the European Union (EU27) together w...
European Surveillance of Veterinary Antimicrobial Consumption (ESVAC): 2009 - 2023
European Sales and Use of Antimicrobials for Veterinary Medicine (ESUAvet) annua...
European sales and use of antimicrobials for veterinary medicine: Annual surveil...
Accelerate biomarker research with high-quality, expert-curated data to drive pr...
Eli Lilly has linked lepodisiran to sustained reductions in a cardiovascular dis...
Vertex is ending work on one of its two islet cell treatments after the diabetes...
Did you know men and women's heart cells prefer different kinds of fuel? Gender ...
“What will be lost when medical students are no longer made to uncomfortably fac...